| Application no. and date | 20728258.3 (espacenet) (Federated) (European Patent Register), 20200424 | | Patent/reg. no. and date | DK/EP 3959235, 20230726 | | Publication date | 20220302 | | Priority no. and date | US 201962839455 P, 20190426, US 202063005041 P, 20200403 | | EP pub. no. and date |
EP 3959235 20220302 | | Effective date | | | Applicant/owner | Allogene Therapeutics, Inc., 210 E. Grand Avenue
South San Francisco, CA 94080, US | | Applicant ref. no. | 1666913 | | Inventor | PERTEL, Thomas Charles, c/o Allogene Therapeutcis, Inc. 210 E. Grand
Avenue
South San Francisco, California 94080, US,
SASU, Barbra Johnson, c/o Allogene Therapeutics, Inc. 210 E. Grand
Avenue
South San Francisco, California 94080, US,
LEONARD, Mark W., c/o Allogene Therapeutics, Inc. 210 E. Grand
Avenue
South San Francisco, California 94080, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , C07K 14/725 (2006.01) | | Title | RITUXIMAB-RESISTENTE KIMÆRE ANTIGENRECEPTORER OG ANVENDELSER DERAF | | Int. application no. | US2020029775 | | Int. publication no. | WO2020219848 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
